About 60 Clinical Studies Regarding Schering-Plough’s Oncology Compounds Will Be Presented At ASCO
Schering-Plough Corporation (NYSE: SGP) announced that about 80 posters, poster discussions, and oral presentations from about 60 clinical studies relating to its growing oncology franchise will be presented at the upcoming 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 30 - June 3.
More: continued here
Filed under: Cancer on June 1st, 2008